markets / Trend

Is there more upside in Tata Motors from its current price of ₹330?

The automobile major has seen a spurt in FY21 sales volume across cars and trucks. Will it sustain? 

markets / Trend

The hazards of asset allocation in a late-stage major bubble

GMO's Jeremy Grantham is certain that the epic bubble, featuring extreme overvaluation and explosive price rise, will burst

markets / Feature

Is Castrol India a mispriced deep value bet or just a dividend play?

The lubricants major’s valuation has eroded over fears of volume contraction due to the onset of electric vehicles  

markets / Trend

When the sun shines

Non-executive director Sudhir Valia sells Sun Pharma stock worth ₹2.91 billion held by Raksha Valia

markets / Feature

RITES is a great play on railways. Fund managers feel not much can go wrong

With a diversified asset-light model and an attractive valuation, this PSU is loved by mutual funds   

markets / Trend

Creating a liquidity buffer

Hero Group promoter Sunil Kant Munjal buys 2% in Lemon Tree as founder Patu Keswani sells stock worth ₹1.67 billion 

markets / Feature

Sleepwell is not the only reason for its dream run. Here’s why investors find Sheela Foam cozy

The decades-old company has built a successful mattress brand and a sound distribution system 

markets / Trend

Awash in cash

With the stock trading near its all-time high, Affle CEO Anuj Khanna Sohum sells stock worth Rs.4.38 billion 

markets / Trend

Is the worst over for hospitality stocks?

With operations resuming, hospitality stocks have put lockdown blues behind them

markets / Trend

Overwhelming green

Pigment manufacturer Sudarshan Chemical’s promoters sell shares worth Rs.841 million 

markets / Feature

Jingoism buried, IPO done, stock price up 50%. What next for Gland Pharma?

Its IPO was talk of the town, but investors gave it a miss. Now, the company is having the last laugh

markets / Trend

Treading with caution

Himadri Speciality Chemical promoters sell shares worth Rs.614 million